Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is one of the hematological malignancies. With the applications of chemotherapy regimens and allogeneic hematopoietic stem cell transplantation, the cure rate of T-ALL has been significantly improved. However, patients with relapsed and refractory T-ALL st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ruyue, Li, Menglin, Wang, Shujuan, Liu, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664086/
https://www.ncbi.nlm.nih.gov/pubmed/33292596
http://dx.doi.org/10.1186/s40164-020-00187-x

Ejemplares similares

Ejemplares similares